JPRN-UMIN000005691
Completed
未知
Evaluation of the efficacy and safety of intravitreal injection of ranibizumab every other month for age-related macular degeneration - Ranibizumab every other month for age-related macular degeneration
Department of Ophthalmology, Shiga University of Medical Science0 sites40 target enrollmentJune 1, 2011
Conditionsage-related macular degeneration
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- age-related macular degeneration
- Sponsor
- Department of Ophthalmology, Shiga University of Medical Science
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •severe glaucoma, inflammation disease, diabetic retinopathy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the efficacy and safety of intravitreal bimonthly injection of aflibercept for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000010312Department of Ophthalmology, Shiga University of Medical Science40
Recruiting
Phase 3
Evaluation of efficacy of recombinant Tissue Plasminogen Activator on facility of vitrectomy for diabetic Tractional Retinal DetachmentIRCT20200217046522N1Iran University of Medical Sciences38
Recruiting
Phase 1
Placenta-derived mesenchymal stem cells and placenta-derived mesenchymal stem cells exosomes in the treatment of acute GvHDAcute GvHD.Graft-versus-host diseaseD89.81IRCT20140818018842N40Tehran University of Medical Sciences60
Completed
Phase 2
Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patientsIRCT20151227025726N20Shahid Beheshti University of Medical Sciences80
Active, not recruiting
Phase 1
Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients with Iron Deficiency AnemiaEUCTR2019-003821-70-PLAmerican Regent, Inc.10